A detailed history of Sapient Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 4,859 shares of ZTS stock, worth $858,779. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,859
Previous 1,554 212.68%
Holding current value
$858,779
Previous $269,000 252.79%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$172.58 - $196.48 $570,376 - $649,366
3,305 Added 212.68%
4,859 $949,000
Q2 2024

Jul 15, 2024

BUY
$145.54 - $178.83 $3,929 - $4,828
27 Added 1.77%
1,554 $269,000
Q1 2024

Apr 22, 2024

SELL
$165.67 - $199.94 $3,313 - $3,998
-20 Reduced 1.29%
1,527 $258 Million
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $91,621 - $121,054
-605 Reduced 28.11%
1,547 $305 Million
Q4 2023

Jan 29, 2024

BUY
$151.44 - $200.09 $325,898 - $430,593
2,152 New
2,152 $425 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.